0001140361-12-019614.txt : 20120405
0001140361-12-019614.hdr.sgml : 20120405
20120405171931
ACCESSION NUMBER: 0001140361-12-019614
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120403
FILED AS OF DATE: 20120405
DATE AS OF CHANGE: 20120405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIRK THOMAS F
CENTRAL INDEX KEY: 0001258258
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 12746491
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0305
4
2012-04-03
0
0000722723
HANGER ORTHOPEDIC GROUP INC
HGR
0001258258
KIRK THOMAS F
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
1
1
0
0
CEO
Common Stock
2012-04-03
4
S
0
10990
21.8168
D
581097
D
Common Stock
2012-04-04
4
S
0
114
21.8004
D
580983
D
Option to Buy
13.50
2004-01-02
2013-01-02
Common Stock
100000
100000
D
Option to Buy
15.67
2005-01-02
2014-01-02
Common Stock
100000
100000
D
Option to Buy
8.08
2006-01-03
2015-01-03
Common Stock
100000
100000
D
The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares.
These shares were sold at a range of sale prices from $21.70 to $21.93. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares totaling 20,000 shares from an initial grant of 20,000 shares of restricted stock made on March 7, 2012, (ii) unvested restricted shares and fully vested shares totaling 63,976 shares from an initial grant of 70,769 shares of restricted stock and performance shares made on March 25, 2011, (iii) unvested restricted shares and fully vested shares totaling 92,596 shares from an initial grant of 115,000 shares of restricted stock and performance shares made on March 30, 2010, (iv) unvested restricted shares and fully vested shares totaling 76,234 shares from an initial grant of 107,730 shares of restricted stock and performance shares made on November 13, 2008, (v) fully vested shares totaling 75,036 shares from an initial grant of 120,000 shares of restricted stock and performance shares made on August 9, 2007, and (vi) fully vested shares totaling 98,175 shares from an initial grant of 110,000 shares of restricted stock made on June 12, 2006.
All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
This option vested over a four-year period from the date of grant and is now fully vested.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas F. Kirk
2012-04-05